Novartis (NVS) announced a planned $23B investment over five years in U.S.-based infrastructure, ensuring all key Novartis medicines for U.S.

After significant industry research on new printing technologies and encountering consistent mentions of Konica Minolta’s digital presses, Shimchock’s recently installed the AccurioLabel 230 and a GM ...